AFC-184CL

antibody from Creative Biolabs

Targeting: CCN2 CTGF, IGFBP8

No application information provided.

Antibody Data

Product number

AFC-184CL

Provider

Creative Biolabs

Product name

Afuco? Anti-Human CTGF ADCC Recombinant Antibody (FG-3019), ADCC Enhanced

Antibody type

Monoclonal

Description

Anti-CTGF ADCC Enhanced Antibody (FG-3019) is an ADCC enhanced antibody produced by our Afuco? platform. FG-3019 is an investigational therapeutic antibody to inhibit the activity of connective tissue growth factor (CTGF), a common factor in chronic fibrotic and proliferative disorders characterized by persistent and excessive scarring that can lead to organ dysfunction and failure. The clinical studies of FG-3019 in idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis show that, it has been well tolerated, with no apparent safety signals, in more than ten clinical studies and more than 340 treated patients to date.

Reactivity

Human

Storage

Store at -20¡ãC. Open under aseptic conditions.